BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17607666)

  • 1. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.
    Sahadevan K; Darby S; Leung HY; Mathers ME; Robson CN; Gnanapragasam VJ
    J Pathol; 2007 Sep; 213(1):82-90. PubMed ID: 17607666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
    Khnykin D; Troen G; Berner JM; Delabie J
    J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
    Cornish EE; Natoli RC; Hendrickson A; Provis JM
    Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
    Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
    J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
    Vlacic G; Hoda MA; Klikovits T; Sinn K; Gschwandtner E; Mohorcic K; Schelch K; Pirker C; Peter-Vörösmarty B; Brankovic J; Dome B; Laszlo V; Cufer T; Rozman A; Klepetko W; Grasl-Kraupp B; Hegedus B; Berger W; Kern I; Grusch M
    Cells; 2019 Sep; 8(9):. PubMed ID: 31527449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.
    Moes-Sosnowska J; Skupinska M; Lechowicz U; Szczepulska-Wojcik E; Skronska P; Rozy A; Stepniewska A; Langfort R; Rudzinski P; Orlowski T; Popiel D; Stanczak A; Wieczorek M; Chorostowska-Wynimko J
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.
    Jain VK; Turner NC
    Breast Cancer Res; 2012 Jun; 14(3):208. PubMed ID: 22731805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
    Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
    PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of fibroblast growth factor receptors in the regenerating amphibian spinal cord in vivo.
    Zhang F; Clarke JD; Santos-Ruiz L; Ferretti P
    Neuroscience; 2002; 114(4):837-48. PubMed ID: 12379240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype.
    Murphy T; Darby S; Mathers ME; Gnanapragasam VJ
    J Pathol; 2010 Mar; 220(4):452-60. PubMed ID: 19960500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
    Li H; Martin A; David V; Quarles LD
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.
    Yan D; Chen D; Cool SM; van Wijnen AJ; Mikecz K; Murphy G; Im HJ
    Arthritis Res Ther; 2011 Aug; 13(4):R130. PubMed ID: 21835001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer.
    Valve EM; Nevalainen MT; Nurmi MJ; Laato MK; Martikainen PM; Härkönen PL
    Lab Invest; 2001 Jun; 81(6):815-26. PubMed ID: 11406643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy.
    Tully KH; Jütte H; Wirtz RM; Jarczyk J; Santiago-Walker A; Zengerling F; Breyer J; Sikic D; Kriegmair MC; von Hardenberg J; Wullich B; Taubert H; Weyerer V; Stoehr R; Bolenz C; Burger M; Porubsky S; Hartmann A; Roghmann F; Erben P; Eckstein M
    Urology; 2021 Nov; 157():93-101. PubMed ID: 34153367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney.
    Cancilla B; Ford-Perriss MD; Bertram JF
    Kidney Int; 1999 Dec; 56(6):2025-39. PubMed ID: 10594778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.
    Cole C; Lau S; Backen A; Clamp A; Rushton G; Dive C; Hodgkinson C; McVey R; Kitchener H; Jayson GC
    Cancer Biol Ther; 2010 Sep; 10(5):495-504. PubMed ID: 20595807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
    Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
    Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.